The Impact of Expandable Cryoballoon on Autonomic Control of the Heart
NCT: NCT06053606 · ACTIVE_NOT_RECRUITING
Brief Summary
Approximately 40% of patients following cryoballoon ablation show signs of parasympathetic denervation. The presence of such effect is related to better outcomes in terms of clinical efficacy (freedom from atrial fibrillation). It could be hypothesized that larger sized balloon (POLARxFIT system) because of more antral position within the left atrium (and hence smaller distance from ganglionated plexi) might enhance this beneficial modulation of the autonomic system of the heart. This study intends to compare the effects of cryoablation employing expandable balloon (POLARxFIT) vs. standard balloon (POLARx) on autonomic system of the heart.
Frequently Asked Questions
What is The Impact of Expandable Cryoballoon on Autonomic Control of the Heart?
The Impact of Expandable Cryoballoon on Autonomic Control of the Heart is a clinical trial registered under NCT06053606. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06053606?
The current status of NCT06053606 (The Impact of Expandable Cryoballoon on Autonomic Control of the Heart) is: ACTIVE_NOT_RECRUITING.
When did The Impact of Expandable Cryoballoon on Autonomic Control of the Heart start?
The Impact of Expandable Cryoballoon on Autonomic Control of the Heart started on 2024-05-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.